Antiretroviral therapy coverage among people living with hiv in Pakistan
Pakistan: Antiretroviral therapy coverage among people living with hiv was 16 in 2024. ◆ Volatile
Antiretroviral therapy coverage among people living with hiv in Pakistan, 2000–2024
Source: Our World in Data.
Analysis
Pakistan recorded 16 for antiretroviral therapy coverage among people living with hiv in 2024. That is the highest value across all 25 years on record.
The figure is up 14.3% on the previous year and up 300.0% over ten years.
Over the whole period, antiretroviral therapy coverage among people living with hiv in Pakistan peaked at 16 in 2024 and was at its lowest, 0, in 2000.
That places Pakistan 142nd out of 143 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage among people living with hiv in Pakistan, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0 | — |
| 2001 | 0 | — |
| 2002 | 2 | — |
| 2003 | 2 | +0.0% |
| 2004 | 1 | -50.0% |
| 2005 | 1 | +0.0% |
| 2006 | 1 | +0.0% |
| 2007 | 1 | +0.0% |
| 2008 | 2 | +100.0% |
| 2009 | 2 | +0.0% |
| 2010 | 2 | +0.0% |
| 2011 | 2 | +0.0% |
| 2012 | 3 | +50.0% |
| 2013 | 3 | +0.0% |
| 2014 | 4 | +33.3% |
| 2015 | 4 | +0.0% |
| 2016 | 5 | +25.0% |
| 2017 | 7 | +40.0% |
| 2018 | 8 | +14.3% |
| 2019 | 11 | +37.5% |
| 2020 | 10 | -9.1% |
| 2021 | 10 | +0.0% |
| 2022 | 12 | +20.0% |
| 2023 | 14 | +16.7% |
| 2024 | 16 | +14.3% |
Pakistan compared with similar countries
- Pakistan's 16 is below the median for lower middle income countries, which is 76, 21% of the median. (39 countries reporting)
- Pakistan's 16 is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 59.5, 27% of the median. (20 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.2 | 0 | 2 | 10 |
| 2010s | 4.9 | 2 | 11 | 10 |
| 2020s | 12.4 | 10 | 16 | 5 |
Countries ranked near Pakistan
More health data for Pakistan
- Un projection of annual infant deaths, annual growth rate -2.14 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8219 % change on previous year (2090)
- Un projection of annual infant deaths 55,286 (2100)
- Neonatal tetanus - number of reported cases, gaps filled 335 (2025)
- Population ages 00-04, female, annual growth rate 0.5028 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0616 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.4109 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, male, per capita 0.0643 units per person (2025)
Frequently asked questions
- What is antiretroviral therapy coverage among people living with hiv in Pakistan?
- Antiretroviral therapy coverage among people living with hiv in Pakistan was 16 in 2024, according to Our World in Data.
- What is the highest antiretroviral therapy coverage among people living with hiv recorded in Pakistan?
- The highest recorded value was 16 in 2024.
- What is the lowest antiretroviral therapy coverage among people living with hiv recorded in Pakistan?
- The lowest recorded value was 0 in 2000.
- How does Pakistan rank for antiretroviral therapy coverage among people living with hiv?
- Pakistan ranks 142nd out of 143 countries with data for 2024.
- Is antiretroviral therapy coverage among people living with hiv rising or falling in Pakistan?
- Over the last ten years it is up 300.0%. The long-run trend across the full record is volatile.
- Where does this Pakistan data come from?
- The figures come from Our World in Data, published as part of Antiretroviral therapy coverage among people living with hiv. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).